- Нет данных
Русский
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, HüBNER Photonics, the leading manufacturer of high-performance lasers, has launched the latest member of the VALO femtosecond series - VALO Tidal. This laser not only represents a major leap in the fields of imaging, detection, and analysis, but also demonstrates the infinite possibilities of laser technology with its outstanding performance.The VALO Tidal femtosecond laser typically sho...
Recently, researchers at the Rensselaer Polytechnic Institute in the United States have invented a miniature device thinner than human hair, which can help scientists explore the essence of light and matter and unravel the mysteries of the quantum field. The most important advantage of this technology is that it can work at room temperature without the need for complex infrastructure. The resea...
Recently, TSMC held a groundbreaking ceremony for its first European 12 inch wafer fab. It is reported that the European Union has approved Germany to provide 5 billion euros in subsidies for the factory.It is understood that TSMC's 12 inch wafer fab is located in Dresden, Germany and is called "European Semiconductor Manufacturing Company (ESMC)". In August 2023, TSMC announced a partnership with...
On August 30th, Changguang Huaxin released its results for the first half of 2023. In the first half of this year, the company achieved a revenue of 142 million yuan, a year-on-year decrease of 43.23%; Net profit attributable to shareholders of the listed company -10.6374 million yuan, a year-on-year decrease of 117.97%.Due to macroeconomic factors such as a slowdown in economic growth, market con...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...